| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.5M | +9.9% |
| R&D Expense | $73.0M | -50.8% |
| SG&A Expense | $40.8M | -31.5% |
| Pre-tax Income | -$68.8M | +59.9% |
| Income Tax | $418K | — |
| Net Income | -$69.2M | +59.7% |
| EPS (Basic) | -$0.56 | +62.2% |
| EPS (Diluted) | -$0.56 | +62.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $107.8M | -38.3% |
| Current Assets | $136.9M | -36.0% |
| Total Assets | $144.7M | -36.0% |
| Current Liabilities | $62.5M | -1.9% |
| Long-term Debt | $10.9M | -52.7% |
| Total Liabilities | $154.2M | -18.5% |
| Stockholders' Equity | -$9.5M | -125.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.3M | +51.2% |
| Capital Expenditures | $132K | -93.9% |
| Investing Cash Flow | $11.4M | -90.5% |
| Financing Cash Flow | $4.1M | -95.7% |
| Free Cash Flow | -$82.5M | +51.8% |